SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Mercury Laboratories

BSE: 538964 29 Jun 2025
Healthcare
₹ 826.2
Mercury Laboratories Limited specializes in Pharmaceuticals within the Healthcare sector.

Mercury Laboratories - Share Price & Details

Market Cap
₹103.0
High /Low
1,190 / 736.0
Stock P/E
32.7
Book Value
₹446.0
Dividend Yield
0.41
ROCE
9.03
ROE
₹6.01
Face Value
10.0
PEG Ratio
-58.4
EVEBITDA
₹13.1
Debt
5.45
CMP / FCF
-182.0
Debt to equity
₹0.1
NP Ann
3.14
High price all time
1,303
Piotroski score
₹5.0
Graham Number
513.0
No. Eq. Shares
0.12
Net CF
₹-6.03
Net profit
3.14
Price to book value
1.92
Interest Coverage
₹9.47
Low price all time
32.5
Industry PE
32.7
Reserves
₹52.4
Free Cash Flow
₹-5.04

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
Mercury Laboratories LimitedNANANANA103.032.7
SOURCE NATURAL FOODS & HERBALNANANANA10235.2
Hemant Surgical Industries LimNANANANA10112.4

Peer Comparison Chart


About Mercury Laboratories

Mercury Laboratories Limited, with Security Code 538964, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

BUMPER dividends by 12 pharma companies: Sun Pharma, Dr Reddy's, Alkem Labs and more - FULL LIST

(23 Jun 2025)
Dividend Paying Stocks, Pharma Stocks Dividend: The companies include Sun Pharma, Alkem Laboratories Ltd, Piramal Pharma Ltd,...
Read more →

The Need to Act Now on Mercury Testing

(30 May 2025)
Public health laboratories play a leading role in the ongoing, successful responses to these threats. While limited resources restrict a laboratory's...
Read more →

Mercury Laboratories Faces Valuation Shift Amid Declining Profits and Market Performance

(20 May 2025)
Mercury Laboratories, a microcap in the Pharmaceuticals & Biotechnology sector, has recently experienced a change in its evaluation.
Read more →

Mercury Labs Standalone March 2025 Net Sales at Rs 20.66 crore, up 18.95% Y-o-Y

(15 May 2025)
Net Sales at Rs 20.66 crore in March 2025 up 18.95% from Rs. 17.37 crore in March 2024. Story continues below Advertisement.
Read more →

Mercury Laboratories Limited recommends final dividend of Rs. 3.50

(15 May 2025)
The Board of Directors of Mercury Laboratories Limited has recommended final dividend @ 35% (Rs 3.50 per share) on the Equity Share Capital...
Read more →

Mercury Laboratories standalone net profit declines 41.88% in the March 2025 quarter

(15 May 2025)
Sales rise 18.94% to Rs 20.66 crore. Net profit of Mercury Laboratories declined 41.88% to Rs 1.11 crore in the quarter ended March 2025 as against Rs 1.91...
Read more →